DrugPatentWatch Database Preview➤ Subscribe for complete access
« Back to Dashboard
Albuterol sulfateis the generic ingredient in sixteen branded drugs marketed by Cipla, Lupin, Padagis Us, Sandoz Inc, Teva Branded Pharm, Kindeva, Glaxosmithkline, Mylan Speciality Lp, Actavis Mid Atlantic, Akorn, Apotex Inc, Bausch And Lomb, Copley Pharm, Landela Pharm, Luoxin Aurovitas, Mylan Speclt, Nephron, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms, Watson Labs, Watson Labs Inc, Wockhardt Eu Operatn, Schering, Amneal Pharms, Chartwell Rx, Cosette, Lannett Co Inc, Mova, Quagen, Teva, Mylan, Muro, Strides Pharma, Am Therap, Amneal Pharms Co, Appco, Aurobindo Pharma Ltd, Eywa, Pliva, Rising, Sun Pharm Industries, Ucb Inc, Virtus Pharm, Warner Chilcott, Zydus Pharms, Boehringer Ingelheim, Fosun Pharma, and Watson Labs Teva, and is included in ninety-nine NDAs. There are thirty-nine patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Albuterol sulfate has four hundred and fifty-five patent family members in thirty-two countries.
There are thirty-eight drug master file entries for albuterol sulfate. Forty-two suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for albuterol sulfate
|Drug Master File Entries:||38|
|Finished Product Suppliers / Packagers:||42|
|Raw Ingredient (Bulk) Api Vendors:||70|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price trends for albuterol sulfate|
|Drug Sales Revenues:||Drug sales revenues for albuterol sulfate|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for albuterol sulfate|
|What excipients (inactive ingredients) are in albuterol sulfate?||albuterol sulfate excipients list|
|DailyMed Link:||albuterol sulfate at DailyMed|
Recent Clinical Trials for albuterol sulfate
Identify potential brand extensions & 505(b)(2) entrants
|Emory University||Phase 1|
|The Marcus Foundation||Phase 1|
|Intech Biopharm Ltd.||N/A|
Generic filers with tentative approvals for ALBUTEROL SULFATE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for albuterol sulfate
|Drug Class|| beta2-Adrenergic Agonist |
|Mechanism of Action||Adrenergic beta2-Agonists |
Paragraph IV (Patent) Challenges for ALBUTEROL SULFATE
|PROVENTIL-HFA||AEROSOL, METERED;INHALATION||albuterol sulfate||020503||2015-05-20|
|PROAIR HFA||AEROSOL, METERED;INHALATION||albuterol sulfate||021457||2012-05-18|
|VOLMAX||TABLET, EXTENDED RELEASE;ORAL||albuterol sulfate||019604|
|Country||Patent Number||Estimated Expiration|
|Eurasian Patent Organization||201300235||⤷ Try it Free|
|Austria||260641||⤷ Try it Free|
|China||105903110||⤷ Try it Free|
|Argentina||064449||⤷ Try it Free|
|Portugal||1667627||⤷ Try it Free|
|Denmark||1330280||⤷ Try it Free|
|Denmark||2514462||⤷ Try it Free|
|>Country||>Patent Number||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.